Literature DB >> 19258079

Evolution in the management of the total thoracic aorta.

Tad Kim1, Tomas D Martin, W Anthony Lee, Philip J Hess, Charles T Klodell, Curtis G Tribble, Robert J Feezor, Thomas M Beaver.   

Abstract

OBJECTIVES: Extensive aneurysms of the ascending, arch, and descending thoracic aorta traditionally have been managed with a 2-stage "elephant trunk" procedure. Single-stage transmediastinal repairs have also been used, because in some patients the entire repair is not completed owing to either complications during first-stage repair or magnitude of the second-stage operation. Since 2006, second-stage elephant trunks have been preferentially completed with endovascular stent grafts in anatomically appropriate patients. This study compares outcomes of 2-stage elephant trunk, single-stage, and hybrid endovascular repairs of extensive thoracic aortic aneurysms.
METHODS: This is a single-institution retrospective cohort study of 103 patients (1992-2007) with extensive thoracic aortic aneurysms undergoing 2-stage elephant trunk repair with either surgical (OPEN) or endovascular (TEVAR) completion versus single-stage transmediastinal replacement (SS). Outcomes were analyzed with Statistica 8.0 software (Tulsa, Okla).
RESULTS: Of 103 patients, 74 had elephant trunk procedures, 24 TEVAR-eligible and 50 OPEN, and 29 had SS. Completion rates were higher with TEVAR than OPEN (78% vs 47%; P = .01). Seven of 18 TEVARs were performed during the index hospitalization. TEVAR patients had shorter second-stage hospital stay (5.5 vs 16.5 days [P < .01]), required fewer transfusions (P < .01), and had less acute kidney injury (P = .04). There were no differences in mortality, paraplegia, or stroke. Six-month Kaplan-Meier survival estimates for OPEN, TEVAR, and SS were 64%, 78%, and 64% (P = .08).
CONCLUSION: More patients complete the second stage when TEVAR is used after elephant trunk repair, with fewer hospital days and transfusions. TEVAR is feasible and safe in the hybrid management of extensive thoracic aortic aneurysms.

Entities:  

Mesh:

Year:  2009        PMID: 19258079     DOI: 10.1016/j.jtcvs.2008.11.012

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Type II arch hybrid debranching procedure.

Authors:  Prashanth Vallabhajosyula; Wilson Y Szeto; Nimesh Desai; Caroline Komlo; Joseph E Bavaria
Journal:  Ann Cardiothorac Surg       Date:  2013-05

2.  Hybrid aortic arch repair: 10-year experience from India.

Authors:  Mohammed Idhrees; Murali Krishnaswami; Aju Jacob; Bashi Velayudhan
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2018-08-16

3.  Debranching solutions in endografting for complex thoracic aortic dissections.

Authors:  Onur Selcuk Goksel; Koray Guven; Celalettin Karatepe; Emre Gok; Bulent Acunas; Bayer Cinar; Ufuk Alpagut
Journal:  Arq Bras Cardiol       Date:  2014-08       Impact factor: 2.000

4.  Thoracic endovascular aortic repair in patients with prior open aortic surgery.

Authors:  Hideyuki Shimizu; Akihiro Yoshitake; Satoshi Kawaguchi; Shinji Kawaguchi; Hidenobu Takaki; Ryohei Yozu
Journal:  Ann Vasc Dis       Date:  2013-02-28

Review 5.  Elephant trunk technique for hybrid aortic arch repair.

Authors:  Yuji Miyamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-15

6.  Results with an algorithmic approach to hybrid repair of the aortic arch.

Authors:  Nicholas D Andersen; Judson B Williams; Jennifer M Hanna; Asad A Shah; Richard L McCann; G Chad Hughes
Journal:  J Vasc Surg       Date:  2012-11-24       Impact factor: 4.268

7.  "V" aortoplasty of the proximal descending aorta in the elephant trunk procedure.

Authors:  Adrian Kolesar; Boris Bily; Lubomir Spak; Jan Luczy; Panagiotis Artemiou; Frantisek Sabol
Journal:  J Cardiothorac Surg       Date:  2015-01-31       Impact factor: 1.637

Review 8.  E-vita open plus for treating complex aneurysms and dissections of the thoracic aorta: a NICE medical technology guidance.

Authors:  Muralikrishnan Radhakrishnan; Janet Peacock; Tiago Rua; Rachel E Clough; Mercy Ofuya; Yanzhong Wang; Elizabeth Morris; Cornelius Lewis; Stephen Keevil
Journal:  Appl Health Econ Health Policy       Date:  2014-10       Impact factor: 2.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.